Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The American Journal of Nursing
|
April 1, 1976
A college contraceptive clinic
S W Andrews
Infection and Immunity
|
June 1, 1987
Acetoin production by wild-type strains and a lactate dehydrogenase-deficient mutant of Streptococcus mutans
J D Hillman, S W Andrews, A L Dzuback
Journal of Dental Research
|
June 1, 1987
Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin
J D Hillman, A L Dzuback, S W Andrews
British Journal of Biomedical Science
|
November 27, 2013
Multiple myeloma: the bone marrow microenvironment and its relation to treatment
S W Andrews, S Kabrah, J E May, et al.
Molecular Pharmacology
|
November 28, 2000
Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter
V L Schuster, S Itoh, S W Andrews, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 1, 1995
Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor
D F Woodward, A M Bogardus, J E Donello, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2003
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)
D F Woodward, A H-P Krauss, J Chen, et al.
Nature Medicine
|
October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
A Vaishnavi, M Capelletti, A T Le, et al.
British Journal of Pharmacology
|
August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds
D F Woodward, A H Krauss, J Chen, et al.
Survey of Ophthalmology
|
July 4, 2001
The pharmacology of bimatoprost (Lumigan)
D F Woodward, A H Krauss, J Chen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The American Journal of Nursing
|
April 1, 1976
A college contraceptive clinic
S W Andrews
Infection and Immunity
|
June 1, 1987
Acetoin production by wild-type strains and a lactate dehydrogenase-deficient mutant of Streptococcus mutans
J D Hillman, S W Andrews, A L Dzuback
Journal of Dental Research
|
June 1, 1987
Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin
J D Hillman, A L Dzuback, S W Andrews
British Journal of Biomedical Science
|
November 27, 2013
Multiple myeloma: the bone marrow microenvironment and its relation to treatment
S W Andrews, S Kabrah, J E May, et al.
Molecular Pharmacology
|
November 28, 2000
Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter
V L Schuster, S Itoh, S W Andrews, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
January 1, 1995
Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor
D F Woodward, A M Bogardus, J E Donello, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2003
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)
D F Woodward, A H-P Krauss, J Chen, et al.
Nature Medicine
|
October 29, 2013
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
A Vaishnavi, M Capelletti, A T Le, et al.
British Journal of Pharmacology
|
August 22, 2000
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds
D F Woodward, A H Krauss, J Chen, et al.
Survey of Ophthalmology
|
July 4, 2001
The pharmacology of bimatoprost (Lumigan)
D F Woodward, A H Krauss, J Chen, et al.
Page
of 1